Guoyuan Lu

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Synthesis, DNA‐Binding, Cleavage, and Cytotoxic Activity of New 1,7‐Dioxa‐4,10‐diazacyclododecane Artificial Receptors Containing Bisguanidinoethyl or Diaminoethyl Double Side Arms

Xin Sheng, Xiaomin Lu, Yueting Chen et al. · Chemistry - A European Journal · 2007 · 113 citations

Pharmacy, Medicinal Chemistry, Molecular Biology +15

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

DNA Binding and Cleaving Activity of the New Cleft Molecule <i>N</i>,<i>N</i>′-Bis(guanidinoethyl)-2,6-pyridinedicarboxamide in the Absence or in the Presence of Copper(II)

Ying Shao, Xin Sheng, Ying Li et al. · Bioconjugate Chemistry · 2008 · 51 citations

Life Sciences, Biochemistry, Molecular Biology +16

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Ellen Burgess, Rajiv Agarwal, Stefan D. Anker et al. · Diabetes Care · 2022 · 35 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17